The increasing cell-based research and the growing number of biotechnology and pharmaceutical companies are driving growth in the cell dissociation market. Emerging economies such as India and Brazil are anticipated to provide considerable growth opportunities for the key players in the cell dissociation market. These economies have emerged favorable for an increased number of research activities in the field of life science leading to a significant amount of growth in the near future in the cell dissociation market. The key objective of the research is to develop new drugs for different diseases. A few pharmaceutical companies are investing a considerable amount in R&D activities such as toxicity studies, efficacy studies, and clinical trials to offer new drugs for commercial use. These studies involve tissue dissociation products to isolate cells from the primary tissues. Therefore, the increasing number of research may generate promising sales opportunities in the cell dissociation market in the near future.
Application of Human and Animal Cells Curbs the Market Growth
To perform R&D activities in cell biology, human cells and animals cells are used in gene therapy studies, and it also involves a combination of stem cell and genes research therapies for credible results. Further, the same cells can be used for pharmacokinetic test of drugs and vivo toxicity. Apart from this, human embryos are used in stem cell research studies for clinical applications, and sometimes it leads to the destruction of human life. Although, ethical authorities have formulated strict rules and regulations to monitor these medical activities.
Among key regions in the cell dissociation market, North America accounts for the largest share in terms of value. The increasing amount of research conducted by biotechnology and pharmaceutical industries in this region is primarily contributing to its growth.